Tocagen

About:

Tocagen is a biopharmaceutical company developing gene therapy products for the treatment of cancer.

Twitter/X: Tocagen

Top Investors: Whiz Partners

Description:

Tocagen is a biopharmaceutical company, engages in the discovery, development, and commercialization of products for the treatment of cancer. It develops gene therapy products for treating primary tumors and metastatic diseases. The company's products comprise Prodrug Activator product candidates for treating glioblastoma multiforme; and immunotherapeutic product candidates for treating metastatic malignant melanoma. Tocagen was founded in 2007 and is based in San Diego, California.

Total Funding Amount:

$199M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Diego, California, United States

Founded Date:

2007-01-01

Founders:

Dennis Berman, Douglas Jolly, Harry Gruber

Number of Employees:

51-100

Last Funding Date:

2018-12-12

IPO Status:

Public

Industries: